The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woo, C.-H.
Right arrow Articles by Kim, J.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woo, C.-H.
Right arrow Articles by Kim, J.-H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2003, 170: 6273-6279.
Copyright © 2003 by The American Association of Immunologists

Transepithelial Migration of Neutrophils in Response to Leukotriene B4 Is Mediated by a Reactive Oxygen Species-Extracellular Signal-Regulated Kinase-Linked Cascade 1

Chang-Hoon Woo*, Min-Hyuk Yoo{dagger}, Hye-Jin You{dagger}, Sung-Hoon Cho{dagger}, Yeung-Chul Mun{ddagger}, Chu-Myong Seong{ddagger} and Jae-Hong Kim2,*

* Graduate School of Biotechnology, Korea University, Anam-dong, Seoul, Korea; {dagger} Department of Life Science, Kwangju Institute of Science and Technology, Kwangju, Korea; and {ddagger} Department of Oncology/Hematology, Ewha Woman’s University, College of Medicine, Seoul, Korea


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The epithelial cells that form a barrier lining the lung airway are key regulators of neutrophil trafficking into the airway lumen in a variety of lung inflammatory diseases. Although the lipid mediator leukotriene B4 (LTB4) is known to be a principal chemoattractant for recruiting neutrophils to inflamed sites across the airway epithelium, the precise signaling mechanism involved remains largely unknown. In the present study, therefore, we investigated the signaling pathway through which LTB4 induces transepithelial migration of neutrophils. We found that LTB4 induces concentration-dependent transmigration of DMSO-differentiated HL-60 neutrophils and human polymorphonuclear neutrophils across A549 human lung epithelium. This effect was mediated via specific LTB4 receptors and was inhibited by pretreating the cells with N-acetylcysteine (NAC), an oxygen free radical scavenger, with diphenylene iodonium (DPI), an inhibitor of NADPH oxidase-like flavoproteins, or with PD98059, an extracellular signal-regulated kinase (ERK) inhibitor. Consistent with those findings, LTB4-induced ERK phosphorylation was completely blocked by pretreating cells with NAC or DPI. Taken together, our observations suggest LTB4 signaling to transepithelial migration is mediated via generation of reactive oxygen species, which leads to downstream activation of ERK. The physiological relevance of this signaling pathway was demonstrated in BALB/c mice, in which intratracheal instillation of LTB4 led to acute recruitment of neutrophils into the airway across the lung epithelium. Notably, the response to LTB4 was blocked by NAC, DPI, PD98059, or CP105696, a specific LTB4 receptor antagonist.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Leukotriene B4 (LTB4)3 is a key mediator of inflammatory processes, immune responses, and host defense against infection (1, 2) and is known to stimulate chemotaxis, degranulation, release of lysosomal enzymes, and reactive oxygen species (ROS) generation (3, 4). Although the precise signaling pathway along which the biological activities of LTB4 are transduced remains largely unknown, it appears to act via two G protein-coupled receptors: LTB4 receptor (BLT1), a high affinity receptor first isolated from HL-60 cells, and BLT2, a low affinity receptor that shares ~45% amino acid identity with BLT1 (5, 6, 7).

Neutrophils are the primary targets of LTB4, and their recruitment to sites of inflammation is one of the principal ways in which LTB4 contributes to inflammatory responses. In particular, the influx of neutrophils into the airway is a common feature of several inflammatory diseases, including acute bronchitis, adult respiratory distress syndrome (ARDS), and chronic obstructive pulmonary disease (COPD) (8, 9), as well as severe asthma (10, 11). Once leukocytes are beyond the endothelial barrier, chemotactic signals frequently lead to their accumulation near mucosal epithelial cells and in the lumen of the airway. Airway epithelial cells may thus be important regulators not only of retention and activation of leukocytes, but also of their passage into the airway itself. It has therefore been suggested that LTB4-induced transepithelial migration of neutrophils plays a crucial role in the pathogenesis of ARDS, COPD, and severe asthma. Yet despite this implication, the signaling pathway via which LTB4 mediates transepithelial migration of neutrophils remains largely unknown.

In the present study, therefore, we investigated the signaling pathway by which LTB4 induces transepithelial migration of neutrophil-like granulocytes (differentiated HL-60 neutrophils (dHL-60)) differentiated from HL-60 cells, which have been shown to be a valid model system for the analysis of human neutrophilic migration and chemotaxis (12), and by human polymorphonuclear neutrophils (PMNs) isolated from healthy volunteers. Our results indicate that LTB4-induced transepithelial migration is accomplished via an ROS-extracellular signal-regulated kinase (ERK)-linked pathway. In addition, the physiological relevance of this pathway was validated in vivo by demonstrating that ROS generation and ERK activation are both required for transmigration of peripheral blood neutrophils across the airway epithelium of BALB/c mice.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Chemicals

2',7'-Dichlorofluorescin diacetate (DCFDA) was purchased from Molecular Probes (Eugene, OR). LTB4APA, LY1718, genistein, and AACOCF3 were obtained from Biomol (Plymouth Meeting, PA). LTB4 and U75302 were purchased from Cayman Chemical Co. (Ann Arbor, MI). BSA, DMSO, PMA, GF109203X, wortmannin, diphenylene iodonium (DPI), and N-acetylcysteine (NAC) were obtained from Sigma-Aldrich (St. Louis, MO). FBS, DMEM, phenol red-free DMEM, gentamicin, and nonessential amino acids were purchased from Life Technologies (Gaithersburg, MD). All other chemicals were obtained from standard sources and were molecular biology grade or higher.

Cell culture and differentiation

Human promyelocytic HL-60 cells obtained from American Type Culture Collection (Manassas, VA; CCL-240) were grown in RPMI 1640 medium supplemented with 10% heat-inactivated FBS, 0.1 mM nonessential amino acids, 50 U/ml penicillin, and 50 µg/ml streptomycin at 37°C under a humidified 95%/5% (v/v) mixture of air and CO2. To induce cells to undergo differentiation along the neutrophil lineage, aliquots of HL-60 cell suspension (5 x 105 cells/ml) were seeded onto dishes and grown for 5 days in the absence or the presence of 1.25% DMSO. Cell differentiation was then evaluated using four criteria (13, 14, 15): 1) morphological changes (nuclear segmentation and granules formation) were analyzed microscopically using H&E cytochemical staining; 2) cell proliferation was assayed with 0.4% trypan blue exclusion; 3) the capacity to reduce nitro blue tetrazolium, a property associated with myeloid cell maturation, was determined spectrophotometrically at 540 nm; and 4) surface expression of differentiation-related Ags was evaluated by flow cytometry using FITC-conjugated mAbs against CD11b, CD16, and CD33. A549 human lung epithelial cells were grown in RPMI containing 10% FBS, 0.1 mM nonessential amino acids, 50 U/ml penicillin, and 100 µg/ml streptomycin. Human PMNs were isolated from blood samples collected from healthy volunteers in heparin sodium salt (100 U; Sigma-Aldrich; H-3149). PMNs were separated on a Ficoll-Paque density gradient (1.077 ± 0.001 g/ml), followed by 2% dextran sedimentation to remove the majority of RBCs (Amersham Pharmacia Biotech, Uppsala, Sweden). Any remaining RBCs were lysed in 0.15 M ammonium chloride solution. The remaining PMNs were suspended in RPMI and used for transepithelial migration assays.

Transepithelial migration assays

Transepithelial migration assays were conducted as previously described (8). Briefly, a collagen-coated, polycarbonate filter insert (5-µm pore size) was placed inside each well of several Transwell 12-well tissue culture plates to create a well within a well, after which 5.2 ml of medium was added to completely submerge the insert. Using sterilized forceps, the insert was then inverted, ensuring that no air bubbles were trapped under it, and exactly 0.8 ml of medium was removed from each well. The insert was then moved to the center of its well to avoid an overlapping meniscus at the edge. Each inverted insert was then gently seeded with a total of 0.5 x 106 A549 cells in two 50-µl aliquots of cell suspension, yielding a configuration in which the cells were growing on the microporous membrane with air above and medium below. The plates were then incubated at 37°C under a 5% CO2 atmosphere for 4–5 days, at which time the inserts were returned to their original orientation for the transmigration experiments. For experimentation, HL-60 cells or PMNs were seeded into the upper chambers of the Transwell system to a density of 5 x 105/well, and the indicated concentrations of LTB4 or saline were added to the lower chambers. After incubating at 37°C in 95%/5% (v/v) mixture of air and CO2 for 6 h, the amount of basal to apical transepithelial migration of dHL-60 or human PMNs was determined by counting the migrated cells on the underside of the insert. When assessing the effects of inhibitors, cells were pretreated with the inhibitor of interest for 20 min before the addition of LTB4.

Measurement of intracellular H2O2

Intracellular H2O2 was measured as a function of DCF fluorescence using a fluorometer. Briefly, HL-60 cells were grown for 5 days in the presence of 1.25% DMSO and then were serum-starved for 6 h in phenol-red free RPMI supplemented 0.5% FBS. To measure intracellular H2O2, cells were then incubated for 10 min with the H2O2-sensitive fluorophore DCFDA (5 µg/ml), which, when taken up, fluorescently labels intracellular H2O2 with DCF. After incubation with DCFDA, cells were exposed to LTB4 or PMA for 5 min and immediately observed under a fluorometer from Molecular Devices (SpectraMAX GeminiXS; Sunnyvale, CA). DCF fluorescence was excited at 488 nm, and the evoked emission was filtered with a 515-nm long-pass filter.

SDS-PAGE and immunoblot analysis

Protein samples were heated at 95°C for 5 min and then subjected by SDS-PAGE on 10% acrylamide gels, followed by transfer to polyvinylidene difluoride membranes using a wet transfer unit (NOVEX, San Diego, CA; for 2 h at 100 V). The membranes were then blocked for 1 h with TBS containing 0.05% (v/v) Tween 20 plus 5% (w/v) nonfat dry milk and incubated, first for 2 h with the primary Ab (1/2000 dilutions of anti-phospho-ERK or anti-p38) in TBS containing 0.05% (v/v) Tween 20 plus 3% (w/v) BSA, and then for 1 h with HRP-conjugated secondary Ab. The bands were developed using an ECL kit and were visualized on XAR-5 film (Eastman Kodak, Rochester, NY).

RNA isolation and RT-PCR

Total cellular RNA was extracted from dHL-60 cells using RNAzol B (Tel-Test, Friendswood, TX), dissolved in diethylpyrocarbonate-treated water, and quantified by UV scanning. One microgram of the extracted RNA was then reverse transcribed by incubating it for 60 min at 37°C in 20 µl in buffer containing 10 mM Tris (pH 8.3); 50 mM KCl; 5 mM MgCl2; 1 mM each of dATP, dCTP, dGTP, and dTTP; and oligo(dT) primers. Hot-start PCR was used to increase the specificity of the amplification with specific primers for human BLT1 (sense, 5'-TATGTCTGCGGAGTCAGCATGTACGC; antisense, 5'-CCTGTAGCCGACGCCCTATGTCCG), human BLT2 (sense, 5'-AGCCTGGAGACTCTGACCGCTTTCG; antisense, 5'-GACGTAGAGCACCGGGTTGACGCTA), and human GAPDH (15). The PCR protocol entailed 25 cycles of denaturation at 94°C for 30 s and elongation at 68°C for 2 min in a Mygenie Thurmal Block from Bioneer (Taejon, Korea). The amplified products were subjected to electrophoresis on 1.8% agarose gels, after which the bands were visualized by ethidium bromide staining and photographed using Polaroid 667 film (Cambridge, MA).

Transient transfection and luciferase assay

Transient transfection was conducted by plating ~2 x 105 cells in 60-mm dishes and then adding Lipofectamine Plus/DNA complex prepared with 1.8 µg of DNA/dish. To control for variations in cell number and transfection efficiency, all clones were cotransfected with 0.4 µg of pSV40-{beta}GAL, a eukaryotic expression vector containing the Escherichia coli {beta}-galactosidase (lacZ) structural gene under transcriptional control of the SV40 promoter. The amount of DNA used in each transfection was held constant (1.8 µg) by adding sonicated calf thymus DNA. To measure ERK’s kinase activity using a PathDetect trans-reporting system (catalog no. 219005; Stratagene, La Jolla, CA), Elk1 fused to trans-activator plasmid was cotransfected with pFR-Luc reporter plasmid according to the manufacturer’s protocol. After incubating for 3 h with the Lipofectamine Plus/DNA complex, the cells were rinsed with serum-free medium and incubated in fresh RPMI 1640 supplemented with 10% FBS for an additional 24 h. The cells in each dish were then treated with LTB4 or control buffer for 6 h, after which they were harvested, lysed in 0.1 ml of lysis solution (0.2 M Tris-Cl (pH 7.6) and 0.1% Triton X-100), and spun for 1 min. The resultant supernatants were assayed for protein and {beta}-galactosidase activity. Luciferase activity was assayed in 10-µl samples of extract. Luciferase luminescence was counted in a luminometer (Turner Design, Sunnyvale, CA; TD-20/20) and normalized to cotransfected {beta}-galactosidase activity (16). Transfection experiments were performed in triplicate using two independently isolated sets of cells, and the results were averaged.

LTB4-challenged mouse model

Pathogen-free female BALB/c mice (8 wk old) were purchased from the Korea Research Institute of Chemistry Technology (Daejon, Korea). The mice were housed throughout the experiments in a laminar flow cabinet and were provided with standard laboratory chow and water ad libitum. For intratracheal administration, mice were anesthetized by i.p. injection of 150 µl of saline containing 13 mg/ml ketamine HCl (Yuhan, Seoul, Korea) and 88.6 µg/ml xylazine (Bayer, Seoul, Korea). LTB4 (Cayman Chemicals, Ann Arbor, MI) was prepared in PBS containing 20% ethanol to a final concentration of 20 µg/ml, and 50 µl was injected intratracheally. After 6 h, bronchoalveolar lavage (BAL) fluid was collected from the lung space as previously described (17). Briefly, the chest cavity was exposed to allow for expansion, after which the trachea was carefully intubated, and the catheter was secured with ligatures. Eight hundred microliters of prewarmed 0.9% NaCl solution was slowly infused into the lung and withdrawn. The aliquots were then pooled and then kept at 4°C. To obtain differential cell counts, the BAL fluid was cytospun and stained with Diff-Quik (Dade Diagnostics, Aguada, Puerto Rico). Two independent, blinded investigators then counted the cells using a hemocytometer. Approximately 400 cells were counted in each of four randomly selected locations. The percentage of neutrophils was multiplied by the total cell number to obtain the neutrophil count. To evaluate lung histology, the lungs were removed from mice 6 h after LTB4 challenge, cut into sections, and stained with H&E (Sigma-Aldrich) (18).

Data analysis and statistics

Data are expressed as mean percentages of control ± SD. Statistical comparisons between groups were made using Student’s t tests. Values of p < 0.01 were considered significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
LTB4-induced transepithelial migration of dHL-60 cells

Human promyelocytic HL-60 cells induced with DMSO to differentiate toward neutrophil-like granulocytes (dHL-60) have been shown to be a valid model system for the analysis of human neutrophil migration and chemotaxis, (12, 19, 20). In the present study LTB4 induced migration of dHL-60 cells, but not the parental HL-60 cells, across a monolayer of A549 human type II alveolar epithelial cells (Fig. 1). The effect was concentration dependent, with 2.3-fold more migration occurring in the presence of 100 nM LTB4 than control buffer.



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 1. LTB4-induced migration of dHL-60 neutrophil-like granulocytes across a monolayer of A549 human lung epithelial cells. Parental and differentiated HL-60 cells were seeded into the upper chambers of a Transwell system to a density of 5 x 105/well, and the indicated concentrations of LTB4 were added to the lower chambers. After 6 h the transmigrated cells were stained with 0.4% trypan blue and counted. The results shown are representative of three independent experiments with similar results.

 
Previous reports have shown that the number of BLTs increases during DMSO-induced differentiation of HL-60 cells (6, 20, 21). Consistent with those reports, RT-PCR showed little or no expression of BLT1 or -2 in parent HL-60 cells, but their expression increased with maturation toward the neutrophil lineage; levels of BLT2, in particular, were dramatically increased during maturation (Fig. 2A).



View larger version (23K):
[in this window]
[in a new window]
 
FIGURE 2. Role of BLTs in LTB4-induced transepithelial migration of dHL-60 cells. A, RT-PCR analysis of BLT1 and BLT2 was conducted using normalized first-strand cDNAs from parental (day 0) and DMSO-differentiated HL-60 cells (3 and 5 days) as templates. The data are representative from three independent experiments with similar results. B, Effect of BLT antagonists on LTB4-induced transepithelial migration of dHL-60 cells. The cells were pretreated with control buffer, U75302 (1 µM), LTB4APA (0.1 µM), or LY1718 (0.1 µM) for 20 min before adding 100 nM LTB4 to the lower Transwell chamber. After 6 h the transmigrated cells were stained with 0.4% trypan blue and counted. Data are expressed as the mean percentage of control ± SD from three independent experiments.

 
With that in mind, we next tested whether the ability of dHL-60 cells to migrate across lung epithelium was a specific result of the increased expression of BLTs by examining the effects of selective BLT antagonists. As shown in Fig. 2B, pretreatment with either U75302 (5), a selective BLT1 antagonist, or LTB4APA, a nonspecific BLT antagonist, significantly diminished LTB4 (100 nM)-induced transepithelial migration of dHL-60 cells, and in combination, they abolished the response. That LTB4APA exerted a more profound inhibitory effect than U75302 suggests that the effect was mediated primarily by BLT2. Consistent with that idea, LTB4 showed biological activity at concentrations of 100–500 nM, which falls within the reported optimal range for BLT2 and is 2 orders of magnitude higher than the optimal range for BLT1. On the other hand, pretreatment with LY1718, a specific cysteinyl LT antagonist, had no inhibitory effect (Fig. 2B).

ROS is critical for the transepithelial migration of dHL-60 cells

Recently, a ROS-dependent pathway was shown to mediate LTB4-induced chemotaxis of Rat-2 fibroblasts (22). To determine whether ROS is similarly involved in the transepithelial migration of dHL-60 cells induced by LTB4, we examined the effect on LTB4-mediated transepithelial migration of ROS inhibition by DPI, an inhibitor of NADPH oxidase-like flavoenzymes, or by NAC, a ROS scavenger. We found that transmigration induced by 100 nM LTB4 was significantly diminished by pretreating dHL-60 cells with DPI and NAC (Fig. 3A). In a similar fashion, pretreatment with DPI or NAC also diminished transmigration induced by PMA. To determine whether LTB4 in fact triggers intracellular ROS generation in dHL-60 cells, we assessed H2O2 levels using DCF. As shown in Fig. 3B, LTB4 elicited a concentration-dependent increase in the level of ROS, and this effect was abolished by pretreating the cells with DPI or NAC (Fig. 3C).



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 3. Role of ROS in LTB4-induced transepithelial migration. A, dHL-60 cells were pretreated with 5 µM DPI or 2 mM NAC for 20 min at room temperature before adding 100 nM LTB4 to the lower Transwell chamber. Transmigrated cells were counted, and the results are expressed as the mean percentage of control ± SD. B, Serum-starved dHL-60 cells were incubated for 5 min with the indicated concentration of LTB4 or 20 ng/ml PMA, after which DCF fluorescence was quantified. Data are expressed as the mean percentage of control ± SD from three independent experiments. C, Serum-starved dHL-60 cells were exposed to 100 nM LTB4 for 5 min in the presence or the absence of 5 µM DPI or 2 mM NAC. Inhibitors were added 20 min before the addition of LTB4. DCF fluorescence was quantified as described in Materials and Methods. Data are expressed as the mean percentage of control ± SD from three independent experiments.

 
LTB4-induced transepithelial migration of dHL-60 cells requires ERK activation

We also observed that in dHL-60 cells LTB4 (100 nM) induced phosphorylation of ERK (Fig. 4A), but not p38 or c-Jun amino-terminal kinase (not shown). To further evaluate ERK stimulation by LTB4, ERK’s kinase activity was assessed using an Elk-luciferase trans-reporter system. We found that LTB4 (100 nM) clearly enhanced ERK/Elk-luciferase activity in differentiated dHL-60 cells, but not in wild-type HL-60 cells (Fig. 4B). Moreover, pretreating the cells with 10 or 20 µM PD98059, a specific mitogen-activated protein kinase kinase inhibitor that blocks ERK activation, dose-dependently inhibited the transepithelial migration induced by 100 nM LTB4 (Fig. 4C). Pretreatment with genistein (10 µM), a nonspecific tyrosine kinase inhibitor, had a similar inhibitory effect.



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 4. Role of ERK activation in LTB4-induced transepithelial migration. A, HL-60 (day 0) or dHL-60 cells (days 3 and 5) were treated with 100 nM LTB4 for 5 min, after which the lysates were immunoblotted with anti-phospho-ERK Ab. The blot was then stripped and reprobed with anti-total ERK Ab. The results shown are representative of at least three independent experiments. B, ERK kinase activity was measured using the Elk-luciferase trans-reporter system as described in Materials and Methods. HL-60 or dHL-60 cells were transiently cotransfected with pFR-Luc reporter plasmid and then treated with 100 nM LTB4 or control buffer for 6 h. The lysates were assayed for Elk-luciferase activity. Data are expressed as the mean ± SD of control values from three independent experiments. C, Effect of ERK inhibition on transepithelial migration of dHL-60 cells. For the inhibitor experiments dHL-60 cells were pretreated for 20 min with control buffer, 10 µM genistein, or the indicated concentration of PD98059 before adding 100 nM LTB4 to the lower Transwell chamber. After 6 h the transmigrated cells were stained with 0.4% trypan blue and counted. Data are expressed as the mean percentage of control ± SD from three independent experiments. D, dHL-60 cells were treated with 100 nM LTB4 for 5 min in the presence or the absence of DPI (5 µM) or NAC (2 mM) and then lysed. The lysates were immunoblotted with anti-phospho-ERKs Ab, after which the blot was stripped and reprobed with anti-total ERKs Ab. The results shown are representative of at least three independent experiments.

 
In a subsequent experiment aimed at determining whether ERK activation is situated upstream or downstream of ROS generation in the LTB4 signaling pathway, we tested the effects of DPI and NAC on LTB4-induced ERK phosphorylation. As shown in Fig. 4D, pretreatment with either NAC or DPI virtually abolished LTB4-induced ERK phosphorylation. Apparently, LTB4 signaling to transmigration of dHL-60 cells is transduced via ERK, most likely acting downstream of ROS.

We further investigated the mediators contributing to LTB4 signaling by testing the effects of inhibitors of phosphatidylinositol 3-kinase (PI 3-kinase), protein kinase C (PKC), and cytosolic phospholipase A2(cPLA2) on transepithelial migration and ERK activation. We found that LTB4-induced transmigration was completely blocked by pretreatment with 0.1 µM wortmannin, a PI 3-kinase inhibitor, or 0.1 µM GF109203X, a PKC inhibitor (Fig. 5A), and there was a corresponding decrease in the level of ERK activation (Fig. 5B), which suggests that both PI 3-kinase and PKC are situated upstream of ERK in the LTB4 signaling pathway. By contrast, AACOCF3 (10 µM), a specific cPLA2 inhibitor, had no effect on either transmigration or ERK activation (Fig. 5).



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 5. Effect of inhibiting PI 3-kinase or PKC on LTB4 signaling and transepithelial migration. A, LTB4-induced transepithelial migration of dHL-60 cells was evaluated in the absence or the presence of control buffer, 0.1 µM wortmannin, 0.1 µM GF109203X, or 20 µM AACOCF3. Cells were preincubated for 20 min with or without the indicated inhibitor before adding 100 nM LTB4 to the lower Transwell chamber. After 6 h the transmigrated cells were stained with 0.4% trypan blue and counted. Data are expressed as the mean percentage of control ± SD from three independent experiments. B, dHL-60 cells were treated with 100 nM LTB4 for 5 min in the presence or the absence of 0.1 µM wortmannin, 0.1 µM GF109203X, or 20 µM AACOCF3 and then lysed. The lysates were immunoblotted with anti-phospho-ERK Ab, after which the blot was stripped and reprobed with anti-total ERK Ab. The results shown are representative of at least three independent experiments.

 
A ROS-ERK-linked cascade is essential for LTB4-induced transepithelial migration of PMNs

The functional importance of this ROS-ERK-linked pathway was further confirmed by investigating its presence in human PMNs obtained from peripheral blood of healthy volunteers. As in dHL-60 cells, LTB4 induced significant transepithelial migration of human PMNs, and the effect was significantly diminished by pretreatment with NAC, DPI, or PD98059 (Fig. 6).



View larger version (43K):
[in this window]
[in a new window]
 
FIGURE 6. Roles of ROS and ERK in the LTB4-induced transepithelial migration of human PMNs. Cells were pretreated for 20 min with control buffer, 5 µM DPI, 2 mM NAC, or 10 µM PD98059 before adding 100 nM LTB4 to the lower Transwell chamber. After 6 h the transmigrated cells were stained with 0.4% trypan blue and counted. Data are expressed as the mean percentage of control ± SD from three independent experiments (p < 0.01).

 
Roles of ROS and ERK in migration of neutrophils across airway epithelium in LTB4-challenged mice

To investigate the physiological function of ROS-ERK-linked signaling in vivo, BALB/c mice were subjected to intratracheal instillation of LTB4. Analysis of BAL fluid revealed that very few neutrophils were present in the airways following intratracheal instillation of saline (Fig. 7); mostly alveolar macrophages were detected. Following instillation of 1 µg of LTB4 in 50 µl of saline, however, the number of neutrophils in the BAL fluid increased significantly within 6 h (Fig. 7, A and B). This effect was blocked by prior i.p. administration of NAC, DPI, PD98059, or the BLT inhibitor CP105696 (Fig. 7C), suggesting that in vivo a ROS-ERK-linked signaling pathway governs LTB4-mediated neutrophil trafficking into the airway.



View larger version (63K):
[in this window]
[in a new window]
 
FIGURE 7. Effects of ROS and ERK inhibitors on LTB4-induced neutrophil trafficking into the lung airway in vivo. BALB/c mice were challenged with intratracheal administration of 1 µg of LTB4 in 50 µl of saline. Six hours later, samples of lung tissue and BAL fluids were collected. The lung samples were sectioned and stained with H&E, and the total and differential cellular components present in the BAL fluid were assessed. Representative H&E-stained lung sections (A) and BAL fluid smears (B) are shown. Each sample was assayed in duplicate, and the assays were repeated three times. Neutrophils in the BAL fluid were counted (C). In some experiments 10 µg/20 g body weight of the indicated inhibitor was administrated i.p. 2 h before intratracheal administration of LTB4. Data are expressed as the mean percentage of control ± SD (p < 0.01).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The epithelial cells that form a barrier lining the airway of the lung are key regulators of neutrophil trafficking into the airway lumen. In that regard, LTB4 is known to be among the most potent of endogenous chemoattractants of PMNs (along with IL-8 and C5a) and to stimulate adhesion of PMNs to airway epithelial cells and transmigration. However, despite its role as a major mediator of PMN transepithelial migration and neutrophil-induced lung injury, little is known about the LTB4 signaling cascade involved in these processes. The major observation of the present study is that a ROS-ERK-linked signaling pathway mediates LTB4-induced transepithelial migration of neutrophils both in vitro and in vivo.

A growing body of evidence suggests that oxygen-derived radicals (e.g., O2- and H2O2) serve as intracellular signaling molecules for a variety of agonists, including LTB4, TNF-{alpha} (16, 23, 24), IL-1 (25), and TGF-{beta}1 (27), as well as various growth factors (27, 28, 29, 30). In the context of the present study it is notable that a ROS-linked cascade was recently shown to mediate LTB4-induced chemotaxis and proliferation of Rat-2 fibroblasts (22), that oxidant stress generated by LTB4 reportedly induces transendothelial migration of monocytes (31, 32), and that ROS reportedly contribute to integrin-dependent cell adhesion (33, 34). Given the inhibitory effect of DPI on LTB4-induced cell migration and ERK activation, we suggest that NADPH oxidase is the primary source of the ROS generated in response to LTB4. Consistent with that idea, several studies have shown that LTB4 promotes robust, receptor-mediated activation of NADPH oxidase (35, 36, 37), which in eosinophils mediates activation of PKC, phospholipases C and D, and cPLA2 (35, 38).

Neutrophils function in the front line of cellular host defense against microorganisms. This function relies in part on their ability to generate large amounts of O2- and related ROS through activation of NADPH oxidase on the plasma membrane, a phenomenon known as respiratory bursting (14, 36, 39). Thus, ROS generation by NADPH oxidase appears to have a dual function, host defense and intracellular signaling, although it remains unknown how the two functions are respectively regulated. The fact that the level of ROS generated by LTB4 is substantially lower than those seen during respiratory bursts suggests that the regulatory mechanisms are quite different.

We were able to demonstrate that ERK mediates ROS signaling to transepithelial migration of neutrophils both in vitro and in vivo (Figs. 4 and 7). In vivo, the process of transepithelial neutrophil migration occurs through a series of steps orchestrated by the interaction of adhesion molecules on the surface of the neutrophils and proteins secreted by the bronchial epithelial cells. Inhibition of ROS or ERK may interfere with any one or more of these steps.

Recently, we and others reported that PI 3-kinase acts as an upstream mediator of ROS generation, leading to chemotaxis and ERK activation (40, 41). Herein we showed that pretreating dHL-60 cells with wortmannin or GF109203X, inhibitors of PI 3-kinase and PKC, respectively, diminished both LTB4-induced transmigration and ERK phosphorylation, suggesting that PI 3-kinase and PKC act upstream of ERK to regulate LTB4 signaling. Consistent with that idea, PMA, an activator of several PKC isoforms, stimulated transepithelial migration of dHL-60 cells, and the effect was significantly diminished by pretreatment with antioxidants.

ROS generation in response to external stimuli has been related to the activation of transcription factors AP-1 and NF-{kappa}B (34), which appear to be involved in the stimulation of the integrins LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18). Although neutrophil adherence and subsequent migration out of postcapillary venules during systemic inflammation are largely dependent on CD18, the existence of CD18-independent neutrophil migration has also been demonstrated (42, 43, 44, 45). For example, when Doerschuk and co-workers (43) compared neutrophil migration in the systemic and pulmonary circulations of rabbits exposed to HCl, Streptococcus pneumonia, E. coli endotoxin, or PMA, they found that migration into the abdominal wall was always CD18 dependent, but migration into the lung was not. Similarly, analysis of neutrophil migration into the inflamed joints of rats with adjuvant arthritis showed that migration could only be completely blocked by combining an anti-CD18 Ab with an Ab recognizing {beta}1 very late Ag 4 (CD49d/CD29). Likewise, monocytes are capable of CD18-independent migration mediated in part by members of the {beta}1 integrin family, very late Ag 4 in particular (44, 45). In addition to integrins, chemokines and proteases, such as elastase, would also seem to be likely downstream targets of ROS-ERK-linked signaling. With further study we anticipate complete clarification of the molecular linkage between the ROS-ERK-linked pathway and its various potential targets. Considering a critical role of LTB4 as a major mediator of PMN transepithelial migration and neutrophil-induced lung injury, specific blockade of the ROS-ERK-linked pathway may have therapeutic value in the treatment of inflammatory diseases such as acute bronchitis, ARDS, COPD, and severe asthma.


    Footnotes
 
1 This work was supported by grants from the Basic Research Program (RO2-2002-000-00029-0), the Science Research Center program (Aging and Apoptosis Research Center), 2002 from the Korea Science and Engineering Foundation, and the Frontier 21 Programs (Proteomics to J.H.K. and Stem Cell to C.M.S.) from the Korea Ministry of Science and Technology. Back

2 Address correspondence and reprint requests to Dr. Jae-Hong Kim, Graduate School of Biotechnology, Korea University, 5-1 Anam-dong, Sungbuk-gu, Seoul 136-701, Korea. E-mail address: jhongkim{at}korea.ac.kr Back

3 Abbreviations used in this paper: LTB4, leukotriene B4; ARDS, adult respiratory distress syndrome; BAL, bronchoalveolar lavage; BLT, LTB4 receptor; COPD, chronic obstructive pulmonary disease; cPLA2, cytosolic phospholipase A2; DCFDA, 2',7'-dichlorofluorescin diacetate; dHL-60, differentiated HL-60 neutrophils; DPI, diphenylene iodonium; ERK, extracellular signal-regulated kinase; NAC, N-acetylcysteine; PMN, polymorphonuclear neutrophil; PI 3-kinase, phosphatidylinositol 3-kinase; PKC, protein kinase C; ROS, reactive oxygen species. Back

Received for publication November 15, 2002. Accepted for publication April 14, 2003.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Brock, T. G., R. W. McNish, M. Peters-Golden. 1995. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J. Biol. Chem. 270:21652.[Abstract/Free Full Text]
  2. Yokomizo, T, T. Izumi, T. Shimizu. 2001. Leukotriene B4: metabolism and signal transduction. Arch. Biochem. Biophys. 385:231.[Medline]
  3. Palmer, R. M., R. J. Stepney, G. A. Higgs, K. E. Eakins. 1980. Chemokinetic activity of arachidonic and lipoxygenase products on leukocytes of different species. Prostaglandins 20:411.[Medline]
  4. Busse, W. W.. 1998. Leukotrienes and inflammation. Am. J. Respir. Crit. Care. Med. 157:S210.[Medline]
  5. Yokomizo, T., K. Kato, K. Terawaki, T. Izumi, T. Shimizu. 2001. A second leukotriene B4 receptor, BLT2: a new therapeutic target in inflammation and immulogical disorders. J. Exp. Med. 192:421.
  6. Yokomizo, T., T. Izumi, K. Chang, Y. Takuwa, T. Shimizu. 1997. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387:620.[Medline]
  7. Yokomizo, T, K. Kato, H Hagiya, T. Izumi, T. Shimizu. 2000. Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J. Biol. Chem. 276:12454.[Abstract/Free Full Text]
  8. Kidney, J. C., D. Proud. 2000. Neutrophil transmigration across human airway epithelial monolayers. Am. J. Respir. Cell Mol. Biol. 23:389.[Abstract/Free Full Text]
  9. Sibille, Y., H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:471.[Medline]
  10. Sur, S., T. B. Crotty, G. M. Kephart, B. A. Hyma, T. V. Colby, C. E. Reed, L. W. Hunt, G. J. Gleich. 1993. Sudden-onset fatal asthma: a distinct entry with few eosinophils and relatively more neutrophils in the airway submucosa?. Am. Rev. Respir. Dis. 148:713.[Medline]
  11. Wenzel, S. E., S. J. Szefler, D. Y. M. Leung, S. I. Sloan, M. D. Rex, R. J. Martin. 1997. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose corticosteroids. Am. J. Respir. Crit. Care Med. 156:737.[Abstract/Free Full Text]
  12. Hauert, A. B., S. Martinelli, C. Marone, V. Niggli. 2002. Differentiated HL-60 cells are a valid model system for the analysis of human neutrophils migration and chemotaxis. Int. J. Biochem. Cell. Biol. 34:838.[Medline]
  13. Falanga, A., R. Consonni, M. Marchetti, G. Locatelli, E. Garattini, C. Gambacorti Passenrini, S. G. Gordon, T. Barbui. 1998. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood 92:143.[Abstract/Free Full Text]
  14. Hua, J., T. Hasebe, A. Someya, S. Nakamura, K. Sugimoto, I. Nagaoka. 2000. Evaluation of the expression of NADPH oxidase components during maturation of HL-60 cells to neutrophils lineage. J. Leukocyte Biol. 68:216.[Abstract/Free Full Text]
  15. Yokomizo, T., T. Izumi, T. Shimizu. 2001. Co-expression of two LTB4 receptors in human mononuclear cells. Life Sci. 68:2207.[Medline]
  16. Woo, C. H., Y. W. Eom, M. H. Yoo, H. J. You, H. J. Han, W. K. Song, Y. J. Yoo, C. S. Chun, J. H. Kim. 2000. Tumor necrosis factor-{alpha} generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J. Biol. Chem. 275:32357.[Abstract/Free Full Text]
  17. Jeong, D. W., M. H. Yoo, T. S. Kim, J. H. Kim, I. Y. Kim. 2002. Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-{kappa}B activation. J. Biol. Chem. 277:17871.[Abstract/Free Full Text]
  18. Yang, L., L. Cohn, D. H. Zhang, R. Homer, A. Ray, P. Ray. 1998. Essential role of nuclear factor {kappa}B in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188:1739.[Abstract/Free Full Text]
  19. Collins, S. J.. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70:1233.[Abstract/Free Full Text]
  20. Patry, C., E. Muller, J. Laporte, M. Rola-Pleszczynski, P. Sirois, A. J. de Brum-Fernandes. 1996. Leukotriene receptors in HL-60 cells differentiated into eosinophils, monocytes and neutrophils. Prostaglandins Leukotrienes Essent. Fatty Acids 54:361.[Medline]
  21. Pettersson, A., A. Boketoft, A. Sabirsh, N. E. Nilsson, K. Kotarsky, B. Olde, C. Owman. 2000. First-generation monoclonal antibodies identifying the human leukotriene B4 receptor-1. Biochem. Biophys. Res. Commun. 279:520.[Medline]
  22. Woo, C. H., H. J. Cho, Y. W. Eom, J. S. Chun, Y. J. Yoo, J. H. Kim. 2002. Leukotriene B4 stimulate Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J. Biol. Chem. 277:8572.[Abstract/Free Full Text]
  23. Lo, Y. Y., T. F. Cruz. 1995. Reactive oxygen species mediate cytokine activation of c-jun N-terminal kinases. J. Biol. Chem. 270:11727.[Abstract/Free Full Text]
  24. Li, Y., A. Ferrante, A. Poulos, D. P. Harvey. 1996. Neutrophil oxygen radical generation: synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids. J. Clin. Invest. 97:1605.[Medline]
  25. Meier, B., H. H. Radeke, S. Selle, G. G. Habermehl, K. Resch, H. Sies. 1990. Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate. Biol. Chem. Hoppe-Seyler 371:1021.[Medline]
  26. Ohba, M., M. Shibanuma, T. Kuroki, K. Nose. 1994. Production of hydrogen peroxide by transforming growth factor-{beta}1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J. Cell Biol. 126:1079.[Abstract/Free Full Text]
  27. Sundaresan, M., Z. X. Yu, V. J. Ferrans, K. Irani, T. Finkel. 1995. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270:296.[Abstract/Free Full Text]
  28. Bae, Y. S., S. W. Kang, M. S. Seo, I. C. Baines, E. Tekle, P. B. Chock, S. G. Rhee. 1997. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide: role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272:217.[Abstract/Free Full Text]
  29. Krieger-Brauer, H. I., H. Kather. 1995. Antagonistic effects of different members of the fibroblast and platelet-derived growth factor families in adipose conversion and NADPH-dependent H2O2 generation in 3T3 L1-cells. Biochem. J. 307:549.
  30. Rhee, S. G.. 1999. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31:53.[Medline]
  31. Rattan, V., C. Sultana, Y. Shen, V. K. Kalra. 1997. Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1. Am. J. Physiol. 273:E453.
  32. Sultana, C., Y. Shen, V. Rattan, C. Johnson, V. K. Kalra. 1998. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 92:3924.[Abstract/Free Full Text]
  33. Blouin, E., L. Halbwachs-Mecarelli, P. Rieu. 1999. Redox regulation of {beta}2-integrin CD11b/CD18 activation. Eur. J. Immunol. 29:3419.[Medline]
  34. Guo, R.-F., P. A. Ward. 2002. Mediators and regulation of neutrophils accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radical Biol. Med. 33:303.[Medline]
  35. Perkins, R. S., M. A. Lindsay, P. J. Barnes, M. A. Giembycz. 1995. Early signaling events implicated in leukotriene B4-induced activation of NADPH oxidase in eosinophils: role of Ca2+, protein kinase C and phospholipase C and D. Biochem. J. 310:795.
  36. Subramanian, N.. 1992. Leukotriene B4 induced steady state calcium rise and superoxide anion generation in guinea pig eosinophils are not related events. Biochem. Biophys. Res. Commun. 187:670.[Medline]
  37. Lindsay, M. A., E. B. Haddad, J. Rousell, M. M. Teixeira, P. G. Hellewell, P. J. Barnes, M. A. Giembycz. 1998. Role of the mitogen-activated protein kinases and tyrosine kinases during leukotriene B4-induced eosinophil activation. J. Leukocyte Biol. 64:555.[Abstract]
  38. Lindsay, M. A., R. S. Perkins, P. J. Barnes, M. A. Giembycz. 1997. Leukotriene B4 activates the NADPH oxidase in eosinophils by a pertussis toxin-sensitive mechanism that is largely independent of arachidonic acid mobilization. J. Immunol. 160:4526.
  39. Dang, P. M., A. R. Cross, B. M. Babior. 2001. Assembly of the neutrophil respiratory burst oxidase: direct interaction between p67PHOX and cytochrome b558. Proc. Natl. Acad. Sci. USA 13:98.
  40. Kim, B. C., M. N. Lee, J. Y. Kim, S. S. Lee, J. D. Chang, S. S. Lee, S. Y. Lee, J. H. Kim. 1999. Roles of phosphatidylinositol 3-kinase and Rac in the nuclear signaling by tumor necrosis factor-{alpha} in rat-2 fibroblasts. J. Biol. Chem. 274:24372.[Abstract/Free Full Text]
  41. Bianca, V. D., S. Dusi, E. Bianchini, I. D. Pra, F. Rossi. 1999. {beta}-Amyloid activates the O2- forming NADPH oxidase in microglia, monocytes, and neutrophils: a possible inflammatory mechanism of neuronal damage in Alzheimer’s disease. J. Biol. Chem. 274:15493.[Abstract/Free Full Text]
  42. Mackarel, A. J., K. J. Russell, C. S. Brady, M. X. FitzGerald, C. M. O’Connor. 2000. Interleukin-8 and leukotriene-B4, but not formylmethionyl leucylphenylalanine, stimulate CD18-independent migration of neutrophils across human pulmonary endothelial cells in vitro. Am. J. Respir. Cell. Mol. Biol. 23:154.[Abstract/Free Full Text]
  43. Doerschuk, C. M., R. K. Winn, H. O. Coxson, J. M. Harlan. 1990. CD18-dependent or -independent mechanisms of neutrophil adherence in the pulmonary and systemic microvasculature of rabbits. J. Immunol. 114:2327.
  44. Shang, X. Z., A. C. Issekutz. 1997. {beta}2 (CD18) and {beta}1 (CD29) integrin mechanisms in migration of human polymorphonuclear leucocytes and monocytes through lung fibroblast barriers: shared and distinct mechanisms. Immunology 92:527.[Medline]
  45. Li, X. C., M. Miyasaka, T. B. Issekutz. 1998. Blood monocyte migration to acute lung inflammation involves both CD18 and very late activation antigen-4-dependent and independent pathways. J. Immunol. 161:6258.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Rittirsch, M. A. Flierl, D. E. Day, B. A. Nadeau, S. R. McGuire, L. M. Hoesel, K. Ipaktchi, F. S. Zetoune, J. V. Sarma, L. Leng, et al.
Acute Lung Injury Induced by Lipopolysaccharide Is Independent of Complement Activation
J. Immunol., June 1, 2008; 180(11): 7664 - 7672.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
K. Kuribayashi, K. Nakamura, M. Tanaka, T. Sato, J. Kato, K. Sasaki, R. Takimoto, K. Kogawa, T. Terui, T. Takayama, et al.
Essential role of protein kinase C {zeta} in transducing a motility signal induced by superoxide and a chemotactic peptide, fMLP
J. Cell Biol., March 26, 2007; 176(7): 1049 - 1060.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Lundeen, B. Sun, L. Karlsson, and A. M. Fourie
Leukotriene B4 Receptors BLT1 and BLT2: Expression and Function in Human and Murine Mast Cells.
J. Immunol., September 1, 2006; 177(5): 3439 - 3447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Sela, N. Mauermann, R. Hershkoviz, H. Zinger, M. Dayan, L. Cahalon, J. P. Liu, E. Mozes, and O. Lider
The Inhibition of Autoreactive T Cell Functions by a Peptide Based on the CDR1 of an Anti-DNA Autoantibody Is via TGF-{beta}-Mediated Suppression of LFA-1 and CD44 Expression and Function
J. Immunol., December 1, 2005; 175(11): 7255 - 7263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Edderkaoui, P. Hong, E. C. Vaquero, J. K. Lee, L. Fischer, H. Friess, M. W. Buchler, M. M. Lerch, S. J. Pandol, and A. S. Gukovskaya
Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase
Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1137 - G1147.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. R. Sheppard, M. R. Kelher, E. E. Moore, N. J. D. McLaughlin, A. Banerjee, and C. C. Silliman
Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation
J. Leukoc. Biol., November 1, 2005; 78(5): 1025 - 1042.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. H. C. Serezani, D. M. Aronoff, S. Jancar, P. Mancuso, and M. Peters-Golden
Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase
Blood, August 1, 2005; 106(3): 1067 - 1075.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Iizuka, T. Yokomizo, K. Terawaki, M. Komine, K. Tamaki, and T. Shimizu
Characterization of a Mouse Second Leukotriene B4 Receptor, mBLT2: BLT2-DEPENDENT ERK ACTIVATION AND CELL MIGRATION OF PRIMARY MOUSE KERATINOCYTES
J. Biol. Chem., July 1, 2005; 280(26): 24816 - 24823.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Sela, R. Hershkoviz, L. Cahalon, O. Lider, and E. Mozes
Down-Regulation of Stromal Cell-Derived Factor-1{alpha}-Induced T Cell Chemotaxis by a Peptide Based on the Complementarity-Determining Region 1 of an Anti-DNA Autoantibody via Up-Regulation of TGF-{beta} Secretion
J. Immunol., January 1, 2005; 174(1): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-H. Woo, J.-H. Lim, and J.-H. Kim
Lipopolysaccharide Induces Matrix Metalloproteinase-9 Expression via a Mitochondrial Reactive Oxygen Species-p38 Kinase-Activator Protein-1 Pathway in Raw 264.7 Cells
J. Immunol., December 1, 2004; 173(11): 6973 - 6980.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Huang, A. Zhao, F. Wong, J. M. Ayala, M. Struthers, F. Ujjainwalla, S. D. Wright, M. S. Springer, J. Evans, and J. Cui
Leukotriene B4 Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes
Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1783 - 1788.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woo, C.-H.
Right arrow Articles by Kim, J.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woo, C.-H.
Right arrow Article